Digital Therapeutics

Digital therapeutic
By Shivan Bhavnani and Ravi N. Shah, MD, MBA 10:12 am November 20, 2020
Considered one of the most innovative areas within digital health, the prescription digital therapeutics (PDT) ecosystem has experienced an accelerated period of progress over the past two years. A prescription digital therapeutic is a prescription-only software that delivers evidence-based therapeutic intervention(s) to prevent, manage or treat a medical disorder or disease.  While considerable...
 The cognitive behavioral therapy for insomnia program is designed to be an end-to-end virtual experience.
By Mallory Hackett 11:18 am November 17, 2020
Pear Therapeutics announced today the availability of its prescription digital therapeutic for chronic insomnia in adults over the age of 22, called Somryst. Somryst uses cognitive behavioral therapy for insomnia (CBTi) to train the brain and body to sleep. Over the course of the patient’s program, the therapy guides them through lessons and challenges, including algorithm-driven sleep...
Vorvida’s virtual cognitive behavioral therapy services displayed on smartphone screen
By Mallory Hackett 11:46 am November 16, 2020
Swedish pharmaceutical and digital therapeutic company Orexo has launched its digital solution for alcohol use disorder, vorvida, through the help of Accenture’s INTIENT Patient platform. The INTIENT Patient platform, which is powered by Google Cloud, supports vorvida’s virtual cognitive behavioral therapy services by providing secure data storage and artificial intelligence-enabled analytics. "...
By Dean Koh 02:57 am November 11, 2020
Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes. The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
Images of the NightWare app on Apple Watches
By Dave Muoio 02:47 pm November 9, 2020
The FDA granted Minneapolis-based NightWare a De Novo clearance on Friday for its Apple Watch and iPhone app designed to improve the sleep quality of those experiencing nightmare disorder and nightmares related to PTSD. The digital therapeutic – which received breakthrough designation from the agency last year – uses the Watch's sensors to track the heart rate and movement of users as they sleep...

Credit: NuvoAir Home platform 

By Sara Mageit 10:30 am November 9, 2020
Studies on paediatric pulmonology from the UK and Sweden have demonstrated that both young and adult patients with respiratory disease can achieve good quality spirometry at home, without clinical supervision, when using the NuvoAir Home platform. The platform includes in-app coaching which provides feedback on techniques to support quality measurements. Other key findings show that patient...
Digital Therapeutics, Juniper Research,
By Sara Mageit 05:18 am October 28, 2020
A study from UK-based analyst house, Juniper Research has found that the number of people using digital therapeutics and wellness apps will grow from 627 million in 2020 to more than 1.4 billion in 2025. This follows regulators responding to COVID-19 by loosening rules that had previously delayed the work of digital therapeutics developers. WHY IT MATTERS The study, called Digital Therapeutics...
Two hands breaking a cigarette in half
By Mallory Hackett 12:46 pm October 8, 2020
The smoking-cessation digital-therapeutic app Quit Genius was found to be an effective treatment for people trying to stop smoking, especially when they are compared to individuals seeking out their own regimen, according to new research from JMIR Mental Health. The results from this study were only indicative for the short term, but researchers noted that a subsequent paper would be published...
By MobiHealthNews 01:51 pm September 25, 2020
It's a bit of a pot pourri this week as the MobiHealthNews team shares some of what it's heard at a variety of (virtual, of course) industry events. First, host Jonah Comstock recaps what Apple announced at its product launch event last week, then Associate Editors Dave Muoio and Mallory Hackett discuss the Digital Therapeutics East event. Last, Managing Editor Laura Lovett and Jonah talk about...
By Dave Muoio 09:45 am September 23, 2020
Cognoa, a digital health company developing software tools for children with autism and other behavioral health conditions and their families, signaled today that it will be moving ahead with a De Novo FDA regulatory submission for its digital autism spectrum disorder (ASD) diagnostic. The tool, which received a Breakthrough Device Designation from the agency in late 2018, is designed to help...